SCHEMBL15427782

SCHEMBL15427782

CNC(=O)c1[nH]c2ccc(OC)cc2c1CCNC(C)=O

nearest known ligand 0.79

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.79
ALDH1A1 P00352 2/20 0.79
HPGD P15428 2/20 0.79
HSD17B10 Q99714 2/20 0.79
POLB P06746 1/20 0.79
MDM2 Q00987 1/20 0.79
NQO2 P16083 3/20 0.73
MTNR1A P48039 17/20 0.72
MTNR1B P49286 17/20 0.72
CYP1A2 P05177 2/20 0.70
CYP3A4 P08684 2/20 0.70
CYP2D6 P10635 2/20 0.70
CYP2C9 P11712 2/20 0.70
CYP2C19 P33261 2/20 0.70
TSHR P16473 1/20 0.70

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16711851 0.91 ALDH1A1 (0.65) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL16711699 0.91 KDM4E (0.69) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL15427770 0.90 KDM4E (0.78) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL3221458 0.90 KDM4E (0.84) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL15427778 0.89 ALDH1A1 (0.63) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL15428037 0.88 KDM4E (1.00) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL16711787 0.88 ALDH1A1 (0.62) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL16711952 0.88 ALDH1A1 (0.62) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL15428094 0.88 ALDH1A1 (0.72) KDM4EALDH1A1HPGDHSD17B10POLB
SCHEMBL15428092 0.88 ALDH1A1 (0.62) KDM4EALDH1A1HPGDHSD17B10POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2873660-B1 INDOLECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC (JP) 2016-10-26 EP claimed
US-9376449-B2 Indole carboxamide derivative ASTELLAS PHARMA INC. (JP) 2016-06-28 US claimed
US-20150203505-A1 INDOLE CARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2015-07-23 US claimed
EP-2873660-A1 INDOLECARBOXAMIDE DERIVATIVE Astellas Pharma Inc. (JP) 2015-05-20 EP claimed
EP-2873660-B1 INDOLECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC (JP) 2016-10-26 EP disclosed
EP-2873660-B1 INDOLECARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC (JP) 2016-10-26 EP disclosed
US-9376449-B2 Indole carboxamide derivative ASTELLAS PHARMA INC. (JP) 2016-06-28 US disclosed
US-9376449-B2 Indole carboxamide derivative ASTELLAS PHARMA INC. (JP) 2016-06-28 US disclosed
US-20150203505-A1 INDOLE CARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2015-07-23 US disclosed
US-20150203505-A1 INDOLE CARBOXAMIDE DERIVATIVE ASTELLAS PHARMA INC. (JP) 2015-07-23 US disclosed
EP-2873660-A1 INDOLECARBOXAMIDE DERIVATIVE Astellas Pharma Inc. (JP) 2015-05-20 EP disclosed
EP-2873660-A1 INDOLECARBOXAMIDE DERIVATIVE Astellas Pharma Inc. (JP) 2015-05-20 EP disclosed
WO-2014010602-A1 INDOLECARBOXAMIDE DERIVATIVE アステラス製薬株式会社 (JP) 2014-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203505-A1 INDOLE CARBOXAMIDE DERIVATIVE MTNR1A, MTNR1B, IDO2 KDM4E 1577/4885ALDH1A1 383/4885HPGD 1972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.